| Abbreviations | Definition |
| AKT1 | AKT Serine/Threonine Kinase 1 |
| AMPK | AMP-activated protein kinase |
| AR | Aldose reductase |
| ASGP | Asialoglycoprotein |
| ATP | Adenosine triphosphate |
| BBB | Blood–brain barrier |
| BAX | Bcl-2-associated X protein |
| BCl-2 | B-cell leukaemia/lymphoma 2 protein |
| CDK4 | Cyclin-dependent kinase 4 |
| CDK6 | Cyclin-dependent kinase 6 |
| CRC | Colorectal cancer |
| ER | Endoplasmic reticulum |
| FK | Fructokinase |
| FOXO | Forkhead box transcription factors |
| F6P | Fructose-6-phosphate |
| FUTs | Fucosyltransferases |
| Gal-dox | Galactose-conjugated doxorubicin |
| Gal-Pt | Galactose-conjugated oxaliplatin |
| GBM | Glioblastoma |
| GlcN | Glucosamine |
| Gluc-PAX | Glucose-conjugated paclitaxel |
| GLUT | Glucose transporter |
| HCFS | High-fructose corn syrup |
| HK | Hexokinase |
| IARC | International Agency for Research on Cancer |
| KHK | Ketohexokinase |
| LDH | Lactate dehydrogenase |
| LLOs | Lipid linked oligosaccharides |
| M6P | Mannose-6-phosphate |
| MTD | Maximum tolerated dose |
| mTOR | Mammalian target of rapamycin |
| NADH | Nicotinamide adenine dinucleotide phosphate hydrogen |
| NAD+ | Nicotinamide adenine dinucleotide phosphate |
| Nrf2 | Erythroid 2-related factor 2 |
| OXPHOS | Oxidative phosphorylation |
| PET | Positron emission tomography |
| PFK | Phosphofructokinase |
| PGI | Phosphogluco isomerase |
| PMI | Phosphomannose isomerase |
| PSAT1 | Phosphoserine aminotransferase |
| Rha-lip | Rhamnose-functionalised liposomes |
| ROS | Reactive oxygen species |
| SLC2A5 | Solute carrier family 2 member 5 |
| STAT | Signal transducer and activator of transcription |
| S1P | Sorbose-1-phosphate |
| TUDCA | Tauroursodeoxycholic acid |
| TXNIP | Thioredoxin-interacting protein |
| UPR | Unfolded protein response |
| WP1122 | 3,6-di-O-acetyl-2-deoxy-ᴅ-glucose |
| 2-BDG | 2-bromo-2-deoxy-ᴅ-glucose |
| 2-CDG | 2-chloro-2-deoxy-ᴅ-glucose |
| 2-DG | 2-deoxy-ᴅ-glucose |
| 2DG-6P | 2-deoxy-ᴅ-glucose-6-phosphate |
| 2-FDG/2-18FDG | 2-deoxy-2(18)fluoro-ᴅ-glucose |
| 2-FDG-PAX | 2-FDG-conjugated paclitaxel |
| 2-XDG | Halogenated 2-deoxy-ᴅ-glucose |
| Cell Line | Tissue or Cell Type |
| A549 | Human lung carcinoma |
| Caco-2 | Human colon carcinoma |
| Ca9-22 | Human gingival squamous carcinoma |
| Caki-1 | Human kidney carcinoma |
| CAL-27 | Human squamous carcinoma |
| C6 | Murine glioma |
| DU145 | Human prostate carcinoma |
| HCT-15 | Human colon carcinoma |
| HCT-116 | Human colon carcinoma |
| HcoEpic | Human colonic epithelial cells |
| HeLa | Human cervical carcinoma |
| HepG2 | Human liver carcinoma |
| HL-60 | Human promyelocytic leukaemia |
| HSC-3 | Human tongue squamous carcinoma |
| HT-29 | Human colon carcinoma |
| Huh-7 | Human liver carcinoma |
| HUVEC | Human umbilical vein endothelium |
| H460 | Human lung carcinoma |
| KP-4 | Human pancreatic carcinoma |
| K562 | Human myelogenous leukaemia |
| L1210 | Human lymphocytic leukaemia |
| MCF-7 | Human breast carcinoma |
| MCF-7/DOX | Human breast carcinoma (doxorubicin-resistant) |
| MDA-MB-468 | Human breast carcinoma |
| MDA-MB-231 | Human breast carcinoma |
| MeWo | Human melanoma |
| MOLT-4F | Human lymphoblastic leukaemia |
| NCI-H23 | Human lung carcinoma |
| N2a | Murine neuroblastoma |
| PANC-1 | Human pancreatic epithelioid carcinoma |
| PC-3 | Human adenocarcinoma |
| RKO | Human colon carcinoma |
| Saos-2 | Human osteosarcoma |
| Sarcoma 37 | Murine soft tissue sarcoma |
| SH-SY5Y | Human neuroblastoma |
| SK-MEL-2 | Human melanoma |
| SK-OV-3 | Human ovarian carcinoma |
| U2OS | Human osteosarcoma |
| U-87MG | Human glioblastoma |
| U-937 | Human lymphoma |
| Walker 256 | Murine breast carcinoma |
| MIA-PaCa-2 | Human pancreatic carcinoma |
| 4T1 | Murine breast/mammary gland |
| 786-O | Human kidney carcinoma |